Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?
Mesut GocerErdal KurtoğluPublished in: Journal of clinical apheresis (2020)
The fact that CD56 residing on the membrane enables interaction between bone marrow cells and ECM and functions as a signal molecule increases sensitivity to the chemotherapy and G-CSF that are used for mobilization. We found that absence of CD56 can be used as a predictive factor for mobilization failure at the time of diagnosis.